CasLoc logo
All Cases PTAB Litigations UPC Oppositions

SANOFI-AVENTIS DEUTSCHLAND GMBH v. GLENMARK PHARMACEUTICALS INC., USA

2:07-cv-05855

Overview

Case Number 2:07-cv-05855
Filing Date 2007-12-07
Status Terminated
Termination Date 2011-09-30
Court District Court, D. New Jersey (njd)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand None

Parties

Defendant

AVENTIS PHARMA S.A. NPE (Individual / Inventor)

Represented By

1 Attorneys Listed

BRIAN M. ENGLISH

TOMPKINS, MCGUIRE, WACHENFELD & BARRY, LLP

Tel: +1 (973) 622-3000

FOUR GATEWAY CENTER, 100 MULBERRY STREET

GLENMARK PHARMACEUTICALS LTD. Operating Company

Represented By

1 Attorneys Listed

ROBERT JOSEPH FETTWEIS

TRESSLER LLP

Tel: +1 (973) 848-2900

744 BROAD STREET, SUITE 1510

GLENMARK PHARMACEUTICALS INC., USA Operating Company

Represented By

1 Attorneys Listed

ROBERT JOSEPH FETTWEIS

TRESSLER LLP

Tel: +1 (973) 848-2900

744 BROAD STREET, SUITE 1510

ABBOTT LABORATORIES NPE (Individual / Inventor)

Represented By

1 Attorneys Listed

BRIAN M. ENGLISH

TOMPKINS, MCGUIRE, WACHENFELD & BARRY, LLP

Tel: +1 (973) 622-3000

FOUR GATEWAY CENTER, 100 MULBERRY STREET

Abbott Laboratories, Inc. Operating Company

Represented By

1 Attorneys Listed

BRIAN M. ENGLISH

TOMPKINS, MCGUIRE, WACHENFELD & BARRY, LLP

Tel: +1 (973) 622-3000

FOUR GATEWAY CENTER, 100 MULBERRY STREET

Plaintiff

ABBOTT GMBH & CO. KG Operating Company

Represented By

1 Attorneys Listed

BRIAN M. ENGLISH

TOMPKINS, MCGUIRE, WACHENFELD & BARRY, LLP

Tel: +1 (973) 622-3000

FOUR GATEWAY CENTER, 100 MULBERRY STREET

SANOFI-AVENTIS DEUTSCHLAND GMBH NPE (Individual / Inventor)

Represented By

1 Attorneys Listed

BRIAN M. ENGLISH

TOMPKINS, MCGUIRE, WACHENFELD & BARRY, LLP

Tel: +1 (973) 622-3000

FOUR GATEWAY CENTER, 100 MULBERRY STREET

Court & Judges

Court

District Court, D. New Jersey (njd)

Global Patent Family Cross-Litigation Radar

CasLoc 360Β° Radar 7 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

πŸ‡ΊπŸ‡Έ
U.S. District Courts Counterparts in force
πŸ›οΈ
USPTO PTAB Trials Counterparts in force
πŸ‡ͺπŸ‡Ί
Unified Patent Court (UPC) Counterparts in force
πŸ‡©πŸ‡ͺ
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (7): πŸ‡©πŸ‡ͺ Germany πŸ‡ΊπŸ‡Έ US
Parallel Proceedings Across Jurisdictions (0 found):

No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.

Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

1 Patent

There is a single patent involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US5721244
Combination of angiotensin-converting enzyme inhibitors with calcium antagonists as well as their use in drugs
Filed: 1995-06-07
Issued: 1998-02-24
Expired (Term Ended)
Expires: 2015-06-07

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. Β§ 283) Statutorily Barred

Statutorily Barred β€” Patent expired. Under 35 U.S.C. Β§ 283, injunctive relief is barred.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term β€” No obviousness-type double patenting noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

50

Dispositive

42

Granted

7

Denied

5

Pending / Review

38

Motions by Category

Procedural / Extension Motion 8 Motion for Summary Judgment (Rule 56) 17 Motion for Preliminary Injunction / TRO 15 Motion to Dismiss 10

Key Dispositive Motions & Rulings

Motion to Dismiss Denied
ORDER denying 207 Motion to Dismiss ; denying 224 Motion for Summary Judgment. Signed by Judge Dennis M. Cavanaugh on 6/30/11. (jd, ) (Entered: 06/30/2011)
Entry #370 • 2011-06-30 Document →
Motion to Dismiss Pending / Under Review
REDACTION to 207 MOTION to Dismiss Abbott Laboratories and Abbott Laboratories, Inc. for Lack of Standing by ABBOTT GMBH & CO. KG, ABBOTT LABORATORIES, AVENTIS ...
Entry #330 • 2011-01-31 Document →
Motion for Summary Judgment (Rule 56) Pending / Under Review
RESPONSE in Support re 224 MOTION for Summary Judgment That the Abbott Plaintiffs Are Not Entitled to Lost Profits filed by GLENMARK PHARMACEUTICALS INC., USA, ...
Entry #256 • 2010-12-13 Document →
Motion for Summary Judgment (Rule 56) Pending / Under Review
STATEMENT of Material Fact in Support re 224 MOTION for Summary Judgment That the Abbott Plaintiffs Are Not Entitled to Lost Profits filed by GLENMARK PHARMACEU...
Entry #257 • 2010-12-13 Document →
Motion for Summary Judgment (Rule 56) Pending / Under Review
BRIEF in Opposition re 224 MOTION for Summary Judgment That the Abbott Plaintiffs Are Not Entitled to Lost Profits (Under Seal) filed by ABBOTT GMBH & CO. KG, A...
Entry #231 • 2010-12-06 Document →
Motion for Summary Judgment (Rule 56) Pending / Under Review
STATEMENT of Material Facts in Opposition re 224 MOTION for Summary Judgment That the Abbott Plaintiffs Are Not Entitled to Lost Profits (Under Seal) filed by A...
Entry #232 • 2010-12-06 Document →

Docket Entries

(452 total)
Pleading / Complaint

COMPLAINT against GLENMARK PHARMACEUTICALS INC., USA, GLENMARK PHARMACEUTICALS LTD. ( Filing fee $ 350 receipt number 1771105.), filed by SANOFI-AVENTIS DEUTSCHLAND GMBH, AVENTIS PHARMA S.A., ABBOTT GMBH & CO. KG, ABBOTT LABORATORIES. (Attachments: # 1 Exhibit A# 2 Exhibit B# 3 Exhibit C# 4 Civil Cover Sheet # 5 Summons GLENMARK PHARM.USA# 6 Summons GLENMARK PHARM LTD)(mn, ) (Entered: 12/11/2007)

Entry #1 • 2007-12-07
1

Corporate Disclosure Statement by SANOFI-AVENTIS DEUTSCHLAND GMBH, AVENTIS PHARMA S.A. identifying SANOF-AVENTIS, S.A. as Corporate Parent.. (mn, ) (Entered: 12/11/2007)

Entry #2 • 2007-12-07
1

Corporate Disclosure Statement by ABBOTT GMBH & CO. KG, ABBOTT LABORATORIES. (mn, ) (Entered: 12/11/2007)

Entry #3 • 2007-12-07
1

Summons Issued as to GLENMARK PHARMACEUTICALS INC., USA, GLENMARK PHARMACEUTICALS LTD..Days Due - 20.(mailed to counsel) (mn, ) (Entered: 12/12/2007)

Entry #4 • 2007-12-12
1

AO120 Patent/Trademark Form filed. (mn, ) (Entered: 12/12/2007)

Entry #5 • 2007-12-12
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc